Inhibition of extracellular lipase from Streptomyces rimosus with 3,4-dichloroisocoumarin

Author： Ašler Ivana Leščić Kovačić Filip Marchetti-Deschmann Martina Allmaier Günter Štefanić Zoran Kojić-Prodić Biserka

Publisher： Informa Healthcare

ISSN： 1475-6366

Source： Journal of Enzyme Inhibition and Medicinal Chemistry, Vol.28, Iss.5, 2013-10, pp. : 1094-1104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Kinetic characterization of lipase inhibition was performed by activity measurement and mass spectrometry (MS), for the first time with serine-protease inhibitor 3,4-dichloroisocoumarin (DCI). Inhibition of Streptomyces rimosus extracellular lipase (SrLip), a member of the SGNH superfamily, by means of DCI follows the mechanism of two-step irreversible inhibition. The dissociation constant of the noncovalent E•I complex and first-order rate constant for inactivation were determined by incubation (K_i* = 26.6 ± 2.8 µM, k₂ = 12.2 ± 0.6 min–1) or progress curve (K_i* = 6.5 ± 1.5 µM, k₂ = 0.11 ± 0.01 min–1) method. Half-times of reactivation for lipase inhibited with 10-fold molar excess of DCI were determined by activity measurement (t_1/2 = 11.3 ± 0.2 h), matrix-assisted laser desorption/ionization (MALDI, t_1/2 = 13.5 ± 0.4 h), and electro-spray ionization (ESI, t_1/2 = 12.2 ± 0.5 h) MS. The active SrLip concentration was determined by incubating the enzyme with near equimolar concentrations of DCI, followed by activity and MS measurement.